Literature DB >> 15234575

Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow.

Annie Pang1, Wing Y Au, Yok L Kwong.   

Abstract

Caveolin-1 is a structural protein that may function as a scaffold for plasma membrane proteins, one of which is P-glycoprotein (P-gp), product of the multidrug resistance-1 (MDR-1) gene. We tested the hypothesis that if P-gp and caveolin-1 interacted physically, caveolin-1 and MDR-1 genes might be coordinately regulated; by quantifiying their gene expression with quantitative-polymerase chain reaction. MDR-1 and caveolin-1 gene expressions were normalized to an internal control and related to a fixed calibrator by a comparative cycle-threshold (CT) method. In four different groups of marrow samples (20 normal, 56 acute myeloid leukemias (AML) at diagnosis, 48 AMLs at relapse, and 51 regenerating marrows), caveolin-1 and MDR-1 gene expressions were positively correlated. In 65 samples with MDR-1 over-expression, caveolin-1 and MDR-1 expressions were also correlated. The coordinate expression of caveolin-1 and MDR-1 suggests that they may either interact physically, or are involved in the same aberrant pathway(s) activated during MDR-1 up-regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234575     DOI: 10.1016/j.leukres.2004.01.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  Role of Caveolin-1 in Indomethacin-induced Death of Human Hepatoadenocarcinoma SK-Hep1 Cells.

Authors:  Kyung-Nam Kim; Ju-Hee Kang; Sung-Vin Yim; Chang-Shin Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

2.  POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.

Authors:  J M Fortier; J E Payton; P Cahan; T J Ley; M J Walter; T A Graubert
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

3.  Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.

Authors:  Hima V Vangapandu; Huiqin Chen; William G Wierda; Michael J Keating; Anil Korkut; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2017-10-03

4.  Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Olsnes Kittang; Randi Hovland; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2011-05-03

5.  S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells.

Authors:  Sayo Suzuki; Yasuko Yamayoshi; Akito Nishimuta; Yusuke Tanigawara
Journal:  Proteome Sci       Date:  2011-12-30       Impact factor: 2.480

6.  Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells.

Authors:  Natalia Diaz-Valdivia; Denisse Bravo; Hernán Huerta; Soledad Henriquez; Fernando Gabler; Margarita Vega; Carmen Romero; Claudia Calderon; Gareth I Owen; Lisette Leyton; Andrew F G Quest
Journal:  BMC Cancer       Date:  2015-06-10       Impact factor: 4.430

7.  Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells.

Authors:  Sayo Suzuki; Yusuke Tanigawara
Journal:  Proteome Sci       Date:  2014-05-09       Impact factor: 2.480

Review 8.  Caveolin-1, a stress-related oncotarget, in drug resistance.

Authors:  Zhiyu Wang; Neng Wang; Pengxi Liu; Fu Peng; Hailin Tang; Qianjun Chen; Rui Xu; Yan Dai; Yi Lin; Xiaoming Xie; Cheng Peng; Honglin Situ
Journal:  Oncotarget       Date:  2015-11-10

Review 9.  Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention.

Authors:  Shengqi Wang; Neng Wang; Yifeng Zheng; Jin Zhang; Fengxue Zhang; Zhiyu Wang
Journal:  Oxid Med Cell Longev       Date:  2017-05-04       Impact factor: 6.543

Review 10.  Lipid rafts: dream or reality for cholesterol transporters?

Authors:  Stéphane Orlowski; Christine Coméra; François Tercé; Xavier Collet
Journal:  Eur Biophys J       Date:  2007-06-19       Impact factor: 2.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.